Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.

NCT04182737 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

356

Enrollment

OTHER

Sponsor class

Conditions

Shock, Septic
Sepsis
Hypoglobulinemia

Interventions

DRUG: IgM-enriched polyclonal immunoglobulins titer-based treatment
DRUG: IgM-enriched polyclonal immunoglobulins Flat treatment

Sponsor

Massimo Girardis